We are one of Canada's top hospital-based research institutes

The Research Institute of the McGill University Health Centre (RI-MUHC) brings together adult and pediatric health research programs, accelerating the translation of biomedical research to improve human health.

RESEARCH PROGRAMS

OUR RESEARCHERS

SERVICES FOR RESEARCH

Clinical Research

Study With Us

Events

Build a career that matters

Work at the RI-MUHC and help us research, innovate and cure.

WORK WITH US

LATEST NEWS

International study offers new path to reduce spinal taps in young infants with fevers

Study compares U.S. and Canadian funding for immigrant heart health research

A rare respiratory disease may be more prevalent in Quebec

When DNA holds the answers: uncovering the genetic roots of infertility

How neurons grow: teamwork behind new dendritic branches

Landmark Canadian-led trial finds many atrial fibrillation patients can stop taking blood thinners

RESEARCH LIFE

null Looking to produce a COVID-19 vaccine in the greenhouse

RI-MUHC researcher working with Quebec-based company on a plant-based technique

Dr. Brian Ward is a senior scientist in the Infectious Diseases and Immunity in Global Health Program at the Research Institute of the MUHC
Dr. Brian Ward is a senior scientist in the Infectious Diseases and Immunity in Global Health Program at the Research Institute of the MUHC

Apr. 22, 2020

Source: Med E-News. McGill researcher Dr. Brian Ward, Professor in the Division of Experimental Medicine in McGill University’s Faculty of Medicine and senior scientist at the Research Institute of the McGill University Health Centre, is working with Quebec-based company Medicago to find a vaccine against SARS-CoV-2, the virus that causes COVID-19, using a plant-based technique that can produce millions of doses in a greenhouse instead of a lab. Read more.

2025 Annual Report

READ NOW